Annual Revenue
N/A
December 31, 2023
Summary
- XENE annual revenue is not available.
Performance
XENE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- XENE quarterly revenue is not available.
Performance
XENE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- XENE TTM revenue is not available.
Performance
XENE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
XENE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
XENE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Xenon Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $9.43 M(-48.8%) | - | - |
| Sep 2022 | - | $132.00 K(-75.4%) | $13.17 M(-37.8%) |
| Jun 2022 | - | $536.00 K(-93.9%) | $21.16 M(-7.4%) |
| Mar 2022 | - | $8.77 M(+134.6%) | $22.84 M(+23.9%) |
| Dec 2021 | $18.44 M(-42.7%) | $3.74 M(-54.0%) | $18.44 M(-7.1%) |
| Sep 2021 | - | $8.12 M(+266.3%) | $19.85 M(+8.6%) |
| Jun 2021 | - | $2.22 M(-49.1%) | $18.28 M(-37.9%) |
| Mar 2021 | - | $4.36 M(-15.4%) | $29.45 M(-8.5%) |
| Dec 2020 | $32.17 M(+371.0%) | $5.15 M(-21.4%) | $32.17 M(+6.0%) |
| Sep 2020 | - | $6.55 M(-51.0%) | $30.34 M(+11.2%) |
| Jun 2020 | - | $13.38 M(+89.1%) | $27.29 M(+96.2%) |
| Mar 2020 | - | $7.08 M(+112.6%) | $13.91 M(+103.6%) |
| Dec 2019 | $6.83 M(+2095.8%) | $3.33 M(-4.9%) | $6.83 M(+95.1%) |
| Sep 2019 | - | $3.50 M(>+9900.0%) | $3.50 M(+1025.4%) |
| Dec 2017 | $311.00 K | $16.00 K(-93.9%) | $311.00 K(-53.7%) |
| Sep 2017 | - | $264.00 K(+1660.0%) | $671.00 K(-18.2%) |
| Jun 2017 | - | $15.00 K(-6.3%) | $820.00 K(-32.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $16.00 K(-95.7%) | $1.22 M(-32.4%) |
| Dec 2016 | $1.80 M(-88.4%) | $376.00 K(-9.0%) | $1.80 M(-61.3%) |
| Sep 2016 | - | $413.00 K(0.0%) | $4.65 M(-45.5%) |
| Jun 2016 | - | $413.00 K(-31.3%) | $8.54 M(-29.9%) |
| Mar 2016 | - | $601.00 K(-81.4%) | $12.17 M(-21.9%) |
| Dec 2015 | $15.58 M(-45.1%) | $3.23 M(-24.8%) | $15.58 M(-9.6%) |
| Sep 2015 | - | $4.29 M(+6.1%) | $17.23 M(-34.1%) |
| Jun 2015 | - | $4.05 M(+0.9%) | $26.13 M(-4.6%) |
| Mar 2015 | - | $4.01 M(-17.8%) | $27.38 M(-3.5%) |
| Dec 2014 | $28.37 M(+3.7%) | $4.88 M(-63.0%) | $28.37 M(-2.4%) |
| Sep 2014 | - | $13.19 M(+149.0%) | $29.07 M(+9.0%) |
| Jun 2014 | - | $5.30 M(+5.9%) | $26.67 M(+24.8%) |
| Mar 2014 | - | $5.00 M(-10.4%) | $21.37 M(+30.5%) |
| Dec 2013 | $27.36 M(+91.2%) | $5.58 M(-48.2%) | $16.37 M(+51.8%) |
| Sep 2013 | - | $10.79 M | $10.79 M |
| Dec 2012 | $14.31 M(+106.8%) | - | - |
| Dec 2011 | $6.92 M | - | - |
FAQ
- What is the all time high annual revenue for Xenon Pharmaceuticals?
- What is the all time high quarterly revenue for Xenon Pharmaceuticals?
- What is the all time high TTM revenue for Xenon Pharmaceuticals?
What is the all time high annual revenue for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual revenue is $32.17 M
What is the all time high quarterly revenue for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly revenue is $13.38 M
What is the all time high TTM revenue for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM revenue is $32.17 M